CP-945,598: Clinical Trials

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	1	Completed 1
Phase 3	1	Completed 1

Follow CP-945,598: new trials by email Literature Review of CP-945,598 trials Research Report on CP-945,598

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects CP-945,598, sibutramine - Obesity	Phase 2 / Phase 3	Completed	Pfizer	282	2005-03-01	2009-08-12

Conditions studied

Obesity (1)

Sponsors

Pfizer (1)

Countries

United States (1)